Replies to post #347554 on NorthWest Biotherapeutics Inc (NWBO)

[trocprofit]

When they repositioned the short-lived CFO, LP took the title back and they have an outside accounting firm who does all the numbers and filings. They present them to LP to sign, then they file. That's my understanding. However, I do not believe the 10Q and topline are related in timing, meaning one HAS to come before he other. When 10Q is done, it will be filed. When topline analysis is complete and PR written, it will be announced (as long as they are comfortable with Journal timing).

[10baggerz]

Interesting point Viking.... FWIW:

On Thu, Jan 14, 2021 at 7:32 AM 10baggerz wrote:
In other words, it wold be a heck of a lot easier for investors to remain patient (and I wouldn’t feel the need to email you) if the company informed us that TLD will be released along with publication. That’s not any sort of prohibited information... Perhaps what you are implying is that the 10Q for 2 quarters ago will explain?
The alternative is to say nothing and watch the stock price collapse as longtime investors get frustrated and sell. For example, today you lost one of your most ardent and intelligent defenders on IHUB:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=160929878

On Thu, Jan 14, 2021 at 7:26 AM 10baggerz wrote:
Thanks for the civil reply to my frustrated email. I know you guys have the long game in mind here, just wish mgmt showed some concern about the FUD created by months of silence after LP/PRs said TLD by end of September 2020 and LG said we’re at the 1/2 yard line in early October and will present TLD before SNO.

My guess is that the Company decided it was more important to have results published in a journal, which I agree with. I just wish that was communicated to investors. In other words, not asking for any information, just an update on the timeline so the FUDsters don’t destroy the stock price while we wait patiently.

On Thu, Jan 14, 2021 at 7:06 AM Dave Innes <[e-mail]> wrote:
Never said you couldn’t ask questions just stated that I could answer as to the reason behind the late filing until q is released . Subtle but large difference

Sent from my iPhone

On Thu, Jan 14, 2021 at 6:54 AM 10baggerz wrote:
How dare an investor have the nerve to ask legitimate questions to investor relations about why the company repeatedly misses about every single timeline provided in official PRs, lied about providing updates, won’t update their SAP, can’t file a quarterly report, won’t update on Swanston as promised, withdraws from conferences, won’t update warrant extensions, and on and on for months and years.

[Legend431]

Then they should find a new company to do the 10-Q